Mathieu Anheim

Summary

Country: France

Publications

  1. doi request reprint Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management
    M Anheim
    Departement de Neurologie, Hopital Civil, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l Hopital, 67000, Strasbourg, France
    Neurogenetics 11:1-12. 2010
  2. ncbi request reprint Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease
    Mathieu Anheim
    Department of Neurology, University Hospital A Michallon, Grenoble, France
    Mov Disord 22:2436-9. 2007
  3. doi request reprint Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients
    M Anheim
    Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS, Universite de Strasbourg, INSERM, Illkirch, France
    Brain 132:2688-98. 2009
  4. doi request reprint Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation
    Mathieu Anheim
    Department of Neurology, University Hospital A Michallon, Grenoble, France
    Arch Neurol 65:612-6. 2008
  5. doi request reprint SPG11 spastic paraplegia. A new cause of juvenile parkinsonism
    Mathieu Anheim
    Dépt de Neurologie, Hopital Civil, Centre Hospitalier Universitaire de Strasbourg 1, Place de l Hopital, 67000 Strasbourg, France
    J Neurol 256:104-8. 2009
  6. pmc Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy
    Stephan Klebe
    INSERM, UMR_S975 CRICM, F 75013 Paris, France
    Brain 135:2980-93. 2012
  7. doi request reprint PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population
    Aurélie Méneret
    INSERM, UMRS 975, Hopital Pitie Salpetriere, Paris, France
    Neurology 79:170-4. 2012
  8. doi request reprint Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases
    Christophe Marcel
    Departement de Neurologie, Hopital Civil de Strasbourg, 1 Place de l Hopital, BP426, 67091 Strasbourg, France
    J Neurol 257:1369-72. 2010
  9. doi request reprint EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?
    Suzanne Lesage
    Universite Pierre et Marie Curie PARIS6, Centre de Recherche de l Institut du Cerveau et de la Moelle Epiniere, UMR S975, INSERM, U975, CNRS, UMR 7225, Hopital de la Pitie Salpetriere, Paris, France
    Neurobiol Aging 33:2233.e1-2233.e5. 2012
  10. doi request reprint Risk factors for spinal cord lesions in dystonic cerebral palsy and generalised dystonia
    Emilie Guettard
    AP HP, Department of Neurology, Groupe Hospitalier Pitie Salpetriere, Paris, France
    J Neurol Neurosurg Psychiatry 83:159-63. 2012

Collaborators

Detail Information

Publications13

  1. doi request reprint Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management
    M Anheim
    Departement de Neurologie, Hopital Civil, Centre Hospitalier Universitaire de Strasbourg, 1, Place de l Hopital, 67000, Strasbourg, France
    Neurogenetics 11:1-12. 2010
    ..The strategic scheme is a useful tool for the diagnosis of ARCAs in clinical practice...
  2. ncbi request reprint Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson's disease
    Mathieu Anheim
    Department of Neurology, University Hospital A Michallon, Grenoble, France
    Mov Disord 22:2436-9. 2007
    ..A close monitoring of patients and an anticipation of IPG replacement in the case of a low-battery signal are recommended...
  3. doi request reprint Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients
    M Anheim
    Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS, Universite de Strasbourg, INSERM, Illkirch, France
    Brain 132:2688-98. 2009
    ..001, P = 0.008 and P = 0.01, respectively). The lack of pyramidal signs in most patients may be explained by masking due to severe motor neuropathy...
  4. doi request reprint Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation
    Mathieu Anheim
    Department of Neurology, University Hospital A Michallon, Grenoble, France
    Arch Neurol 65:612-6. 2008
    ..The misplacement of electrodes is a possible explanation for suboptimal response to bilateral subthalamic nucleus (STN) stimulation in patients with Parkinson disease...
  5. doi request reprint SPG11 spastic paraplegia. A new cause of juvenile parkinsonism
    Mathieu Anheim
    Dépt de Neurologie, Hopital Civil, Centre Hospitalier Universitaire de Strasbourg 1, Place de l Hopital, 67000 Strasbourg, France
    J Neurol 256:104-8. 2009
    ..704_705delAT, p.H235RfsX12 homozygous mutation in SPG11. This report provides evidence that parkinsonism may initiate SPG11-linked HSP TCC and that SPG11 may cause juvenile parkinsonism...
  6. pmc Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy
    Stephan Klebe
    INSERM, UMR_S975 CRICM, F 75013 Paris, France
    Brain 135:2980-93. 2012
    ..Altogether, these results emphasize the clinical variability associated with SPG7 mutations, ranging from optic neuropathy to spastic paraplegia, and support the view that SPG7 screening should be carried out in both conditions...
  7. doi request reprint PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population
    Aurélie Méneret
    INSERM, UMRS 975, Hopital Pitie Salpetriere, Paris, France
    Neurology 79:170-4. 2012
    ..Mutations in the PRRT2 gene were recently identified in patients with PKD and ICCA. We studied the prevalence of PRRT2 mutations and characteristics of the patients in a European population of patients with PKD and ICCA...
  8. doi request reprint Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases
    Christophe Marcel
    Departement de Neurologie, Hopital Civil de Strasbourg, 1 Place de l Hopital, BP426, 67091 Strasbourg, France
    J Neurol 257:1369-72. 2010
    ..The best clinical signs for distinguishing between symptomatic and primary PDA are adult onset and short (<1 min) episodes in the former. If these signs are present, brain MRI should be used to identify a cause of symptomatic PDA...
  9. doi request reprint EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?
    Suzanne Lesage
    Universite Pierre et Marie Curie PARIS6, Centre de Recherche de l Institut du Cerveau et de la Moelle Epiniere, UMR S975, INSERM, U975, CNRS, UMR 7225, Hopital de la Pitie Salpetriere, Paris, France
    Neurobiol Aging 33:2233.e1-2233.e5. 2012
    ..G686C) and in a control subject (p.R1197W). These data do not support the pathogenicity of several EIF4G1 variants in PD, at least in the French population...
  10. doi request reprint Risk factors for spinal cord lesions in dystonic cerebral palsy and generalised dystonia
    Emilie Guettard
    AP HP, Department of Neurology, Groupe Hospitalier Pitie Salpetriere, Paris, France
    J Neurol Neurosurg Psychiatry 83:159-63. 2012
    ..The aim of this study is to identify the risk factors and clinical characteristics of CM in patients with generalised dystonia, including dystonic CP...
  11. doi request reprint Clinical and molecular findings of ataxia with oculomotor apraxia type 2 in 4 families
    Mathieu Anheim
    Departement de Neurologie, Hopital Civil, 1 Place de l Hopital, 67091 Strasbourg, France
    Arch Neurol 65:958-62. 2008
    ....
  12. pmc ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency
    Clotilde Lagier-Tourenne
    Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS INSERM Universite Louis Pasteur, et Collège de France, Chaire de Génétique Humaine, 67404 Illkirch, France
    Am J Hum Genet 82:661-72. 2008
    ....
  13. ncbi request reprint Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations
    Michael Schüpbach
    centre d investigation clinique, Hopital de la Pitie Salpetriere, AP HP, Paris, France
    Mov Disord 22:119-22. 2007
    ..Two patients with the G2019S LRRK2 mutation still benefited from STN stimulation, 9 and 10 years after surgery. Patients with LRRK2 mutations are, therefore, good candidates for STN stimulation...